publicaciones seleccionadas
-
documento
- Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence 2018
- Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia 2014
- COST OF OUTBREAK OF MENINGOCOCCAL DISEASE IN A COLOMBIAN CARIBBEAN CITY, 2012 2013
- COST-EFFECTIVENESS ANALYSIS OF INTRODUCTION OF MENINGOCOCCAL CONJUGATE VACCINE IN COLOMBIA, 2011 2013
- COST-EFFECTIVENESS ANALYSIS OF USING HYPOGLYCEMIC AGENTS (LINAGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN, GLIMEPIRIDE AND GLIBENCLAMIDE) WITH METFORMIN IN DIABETES IN COLOMBIA 2013
- Healthcare costs in Colombian patients infected with Acinetobacter baumannii,Costos en pacientes con infección por Acinetobacter baumannii en Colombia 2013
- IMPACT ANALYSIS IN THE DEMAND FOR TECHNOLOGIES INCLUDED IN THE COLOMBIAN BENEFIT PLAN BACK TO ITS UPDATE IN 2012 2013
- COST-EFFECTIVENESS ANALYSIS OF INTRODUCING HPV VACCINES IN COLOMBIAN WOMEN 2012
- COSTS OF PROBABLE BACTERIAL PNEUMONIA IN CHILDREN UNDER 5 YEARS OLD IN COLOMBIA 2012
- COSTS OF PROBABLE VIRAL DIARRHEA IN CHILDREN UNDER FIVE YEARS OLD IN COLOMBIA 2012
- REVIEW OF ADMINISTRATION'S COST ASSUMPTION OF ROTAVIRUS AND PNEUMOCOCCAL VACCINES COST-EFFECTIVENESS ANALYSES 2012
- USE OF CENTRALIZED NATIONAL DATA TO ESTIMATE COSTS OF EPI AT NATIONAL LEVEL. THE BOLIVIAN CASE, 2007-2009 2012
- Acinetobacter baumanniirelated mortality in intensive care units in Colombia,Mortalidad por Acinetobacter baumannii en unidades de cuidados intensivos en Colombia 2011
- Author's reply,Respuesta de autor 2011
- BUDGETARY IMPACT OF THE USE OF LEVONORGESTREL-UIS COMPARED TO OTHER TREATMENTS IN IDIOPATHIC MENORRHAGIA IN COLOMBIA 2011
- COST ANALYSIS OF THE EXPANDED PROGRAM OF IMMUNIZATIONS IN COLOMBIA 2009 2011
- COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF ACELLULAR PERTUSSIS IN COLOMBIAN ADOLESCENTS 2011
- COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIA 2011
- COST-EFFECTIVENESS OF A CATCH-UP DOSE OF HEPATITIS B VACCINE IN COLOMBIAN ADOLESCENTS 2011
- COST-EFFECTIVENESS OF LEVONORGESTREL-UIS USE COMPARED TO OTHER TREATMENTS IN IDIOPATHIC MENORRHAGIA 2011
- COST-EFFECTIVENESS OF USING DETEMIR IN TYPE 2 DIABETES WITH THE RISK OF CARDIOVASCULAR EVENTS AND DEATH 2011
- EFFECT OF BIOMASS SMOKE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RURAL LOCALITIES OF COLOMBIA 2011
- Epidemiological and economic impact of tetanus vaccination in Colombian adults,Impacto epidemiológico y económico de la vacunación contra el tétanos en adultos de Colombia 2011
- RAPID ASSESSMENT OF THE IMPACT OF THE INTRODUCTION OF ROTAVIRUS VACCINE IN COLOMBIA 2011
- UTILITY-COST ANALYSIS OF RITUXIMAB AFTER FAILURE OF ANTI-TNF IN RHEUMATOID ARTHRITIS FOR COLOMBIA 2011
- COST-EFFECTIVENESS ANALYSIS OF CHANGING FROM LIVE ORAL POLIOVIRUS VACCINE TO INACTIVATED POLIOVIRUS VACCINE IN COLOMBIA 2010
- COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE POLYVALENT (PPSV23) IN ADULTS OLDER THAN 60 YEARS OLD IN COLOMBIA 2010
- Economic impact of introducing the injectable inactivated polio vaccine in Colombia,Impacto económico de la introducción de la vacuna inactivada inyectable contra la poliomielitis en Colombia 2010
- QALYS and DALYS as synthetic indicators of health,Los QALYS y DALYS como indicadores sintéticos de salud 2010
- Theoretical estimation of the epidemiological impact of hepatitis a infection in Colombia,Estimación del impacto de la infección por hepatitis a en zonas urbanas de Colombia 2008. un análisis a partir de datos secundarios 2010
- AN ECONOMIC EVALUATION OF A PHARMACOLOGICAL INTERVENTION USING VARENICLINE AS THERAPY FOR SMOKING CESSATION 2009
- ANALYSIS OF COST EFFECTIVENESS AND COST UTILITY OF INTERFERON BETA-1B (INFB1B) VERSUS INTERFERON BETA-1A (INFB1A) FOR TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN COLOMBIA 2009
- ASSESSMENT OF THE BURDEN OF DISEASE BY HUMAN PAPILLOMAVIRUS IN BOGOTA, COLOMBIA 2009
- COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE IN COLOMBIA IN 2007 2009
- COSTS OF MULTIPLE SCLEROSIS IN COLOMBIA 2009
- ECONOMIC IMPACT ASSESSMENT OF THE INTRODUCTION OF HEPATITIS A VACCINE IN BOGOTA D.C 2009
- ECONOMIC IMPACT ASSESSMENT OF THE INTRODUCTION OF PNEUMOCOCCAL VACCINE IN BOGOTA, D. C 2009
- EPIDEMIOLOGICAL AND ECONOMIC IMPACT OF INTRODUCTION TO A HEPATITIS A VACCINE IN COLOMBIA 2009
- EPIDEMIOLOGICAL AND ECONOMIC IMPACT OF THE INTRODUCTION OF INFLUENZA VACCINE IN COLOMBIA 2009
- EPIDEMIOLOGICAL EVALUATION AND ECONOMIC IMPACT OF THE INTRODUCTION OF ROTAVIRUS VACCINE IN THE LAND OF BOGOTA, D. C 2009
- EPIDEMIOLOGICAL EVALUATION AND ECONOMIC IMPACT OF THE INTRODUCTION OF ROTAVIRUS VACCINE IN THE LAND OF COLOMBIA 2009
- Health research priorities in Colombia from the researchers' point of view,Prioridades de Investigación en Salud en Colombia: Perspectiva de los Investigadores 2009
- SMOKING-ATTRIBUTABLE BURDEN OF FOUR TOBACCO-RELATED DISEASES IN COLOMBIA IN 2007 2009
- A high prevalence of antibodies against Bartonella and Babesia microti has been found in villages and urban populations in Cordoba, Colombia,Alta prevalencia de anticuerpos contra Bartonella y Babesia microti en poblaciones rurales y urbanas en dos provincias de Córdoba, Colombia 2008
- Agreement between methods for antimicrobial susceptibility to Mycobacterium tuberculosis strains isolated in Montería, Córdoba: Mycobacteria growth indicator tube vs. proportion method,Concordancia de métodos para susceptibilidad antimicrobiana en cepas de Mycobacteríum tuberculosis aisladas en Montería, Córdoba: Tubo indicador de crecimiento micobacteriano vs. método de la proporciones múltiples 2008
- Cost-effective analysis of the technical use of subarachnoid anesthesia compared with general anesthesia for open cholecystectomy 2008
- Economic evaluation of sunitinib vs. interferon-alfa (IFN-alfa) in first-line treatment of Metastatic Renal Cell Carcinoma (MRCC) in Colombia 2008
- Sexually-transmitted infection in a high-risk group from Montería, Colombia,Infecciones de transmisión sexual en un grupo de alto riesgo de la Ciudad de Montería, Colombia 2007
- Acute meningitis in Córdoba, Colombia (2002-2004),Meningitis agudas en Córdoba, Colombia 2002-2004 2006
- Occupational leptospirosis in a Colombian Caribbean area,Leptospirosis ocupacional en una región del Caribe Colombiano 2005
- AIDS mortality and its economic impact in Cartagena de Indias, Colombia, 1995-2000,La mortalidad por SIDA y su impacto económico en Cartagena de Indias, Colombia, 1995-2000. 2002